Accession Number: | 0000899243-19-026148 |
Date: | 2019-10-25 |
Issuer: | HAEMONETICS CORP (HAE) |
Original Submission Date: |
GOLDSTEIN DAN
400 WOOD ROAD
BRAINTREE, MA 02184
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2019-10-25 | M | 1,456 | a | $34.21 | 4,245 | direct | ||
COMMON STOCK | 2019-10-25 | S | 1,456 | d | $120.32 | 2,789 | direct | ||
COMMON STOCK | 2019-10-28 | S | 100 | d | $120.33 | 2,689 | direct | ||
COMMON STOCK | 2019-10-29 | S | 237 | d | $122.69 | 2,452 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
NON-QUALIFIED STOCK OPTION (RIGHT TO BUY) | 34.21 | 2019-10-25 | deemed execution date | M | 1,456 (d) | 2019-10-25 | 2023-10-25 | common stock 1,456 | $34.21 | 1,457 | direct |
ID | footnote |
---|---|
f1 | transaction pursuant to an existing 10b5-1. |
f2 | this number includes unvested restricted stock units previously reported. |
f3 | represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units previously reported in table i following the date of grant. this sale is mandated by the issuer's election under its 2005 long term incentive compensation plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. |
f4 | option vests in annual increments of 25% beginning on the first anniversary of the date of grant. |